Low striatal dopamine receptor availability linked to caloric intake during abstinence from chronic methamphetamine abuse

Molecular Psychiatry

Volumn 17, Issue 6, 2012, Pages 569-571

  Zorick, T ^a,b   Lee, B ^a   Mandelkern, M A ^c   Fong, T ^a   Robertson, C ^d   Ghahremani, D G ^a   Brown, A K ^a   Sumerel, B ^a   London, E D ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; METHAMPHETAMINE; NEUROLEPTIC AGENT;

BODY MASS; CALORIC INTAKE; DRUG ABUSE; DRUG DEPENDENCE; DRUG URINE LEVEL; DRUG WITHDRAWAL; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LETTER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SMOKING; TOBACCO DEPENDENCE; WEIGHT GAIN;

ADULT; AMPHETAMINE-RELATED DISORDERS; ENERGY INTAKE; FEMALE; HUMANS; MALE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84861457949     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2011.137     Document Type: Letter

References (9)

1. United Nations Office on Drugs and Crime. World Drug Report. United Nations Publications: New York, NY, 2010.
2. World Health Organization. Obesity and Overweight, Fact Sheet No 311, March 2011. http://www.who.int/mediacentre/factsheets/ fs311/en/, accessed 20 April 2011.
3. Volkow ND, Wang GJ, Baler RD. Trends Cogn Sci 2011; 15: 37-46.
4. Blum K, Liu Y, Shriner R, Gold MS. Curr Pharm Des 2011; 17: 1158-1167.
5. Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR et al. J Neurosci 2009; 29: 14734-14740.
6. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu Wet al. Lancet 2001; 357: 354-357.
7. Ishibashi K, Ishii K, Oda K, Kawasaki K, Mizusawa H, Ishiwata K. Synapse 2009; 63: 282-290.
8. Perez GA, Haney M, Foltin RW, Hart CL. Pharmacol Biochem Behav 2008; 90: 717-722.
9. Lee SY, Park MH, Patkar AA, Pae CU. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 490-496.